2013-2028 Report on Global Site-Specific Drug Delivery Market by Player, Region, Type, Application and Sales Channel


Report ID : RC-51125 Category : Medical Devices
Published Date : Oct-19 Pages : 123 Format : PDF
The global Site-Specific Drug Delivery market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Site-Specific Drug Delivery from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Site-Specific Drug Delivery market.

Leading players of Site-Specific Drug Delivery including:
    Johnson & Johnson
    Gilead Sciences
    Pacira
    Sun Pharmaceutical
    Luye Pharma
    Sigma-Tau Group
    Fudan-Zhangjiang
    Teva Pharmaceutical
    CSPC
    Novartis
    Kingond Pharm

Market split by Type, can be divided into:
    Liposomal Doxorubicin
    Liposomal Amphoteracin B
    Liposomal Paclitaxel
    Other

Market split by Application, can be divided into:
    Fungal Infection Therapy
    Cancer & Tumor Therapy
    Other

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Site-Specific Drug Delivery Market Overview
    1.1 Site-Specific Drug Delivery Definition
    1.2 Global Site-Specific Drug Delivery Market Size Status and Outlook (2013-2028)
    1.3 Global Site-Specific Drug Delivery Market Size Comparison by Region (2013-2028)
    1.4 Global Site-Specific Drug Delivery Market Size Comparison by Type (2013-2028)
    1.5 Global Site-Specific Drug Delivery Market Size Comparison by Application (2013-2028)
    1.6 Global Site-Specific Drug Delivery Market Size Comparison by Sales Channel (2013-2028)
    1.7 Site-Specific Drug Delivery Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Site-Specific Drug Delivery Market Segment Analysis by Player
    2.1 Global Site-Specific Drug Delivery Sales and Market Share by Player (2016-2018)
    2.2 Global Site-Specific Drug Delivery Revenue and Market Share by Player (2016-2018)
    2.3 Global Site-Specific Drug Delivery Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Site-Specific Drug Delivery Market Segment Analysis by Type
    3.1 Global Site-Specific Drug Delivery Market by Type
        3.1.1 Liposomal Doxorubicin
        3.1.2 Liposomal Amphoteracin B
        3.1.3 Liposomal Paclitaxel
        3.1.4 Other
    3.2 Global Site-Specific Drug Delivery Sales and Market Share by Type (2013-2018)
    3.3 Global Site-Specific Drug Delivery Revenue and Market Share by Type (2013-2018)
    3.4 Global Site-Specific Drug Delivery Average Price by Type (2013-2018)
    3.5 Leading Players of Site-Specific Drug Delivery by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Site-Specific Drug Delivery Market Segment Analysis by Application
    4.1 Global Site-Specific Drug Delivery Market by Application
        4.1.1 Fungal Infection Therapy
        4.1.2 Cancer & Tumor Therapy
        4.1.3 Other
    4.2 Global Site-Specific Drug Delivery Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Site-Specific Drug Delivery by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Site-Specific Drug Delivery Market Segment Analysis by Sales Channel
    5.1 Global Site-Specific Drug Delivery Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Site-Specific Drug Delivery Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Site-Specific Drug Delivery by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Site-Specific Drug Delivery Market Segment Analysis by Region
    6.1 Global Site-Specific Drug Delivery Market Size and CAGR by Region (2013-2028)
    6.2 Global Site-Specific Drug Delivery Sales and Market Share by Region (2013-2018)
    6.3 Global Site-Specific Drug Delivery Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Site-Specific Drug Delivery Market Share by Type
        6.4.3 North America Site-Specific Drug Delivery Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Site-Specific Drug Delivery Market Share by Type
        6.5.3 Europe Site-Specific Drug Delivery Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Site-Specific Drug Delivery Market Share by Type
        6.6.3 Asia-Pacific Site-Specific Drug Delivery Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Site-Specific Drug Delivery Market Share by Type
        6.7.3 South America Site-Specific Drug Delivery Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Site-Specific Drug Delivery Market Share by Type
        6.8.3 Middle East & Africa Site-Specific Drug Delivery Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Site-Specific Drug Delivery Players
    7.1 Johnson & Johnson
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Gilead Sciences
    7.3 Pacira
    7.4 Sun Pharmaceutical
    7.5 Luye Pharma
    7.6 Sigma-Tau Group
    7.7 Fudan-Zhangjiang
    7.8 Teva Pharmaceutical
    7.9 CSPC
    7.10 Novartis
    7.11 Kingond Pharm
Chapter 8 Upstream and Downstream Analysis of Site-Specific Drug Delivery
    8.1 Industrial Chain of Site-Specific Drug Delivery
    8.2 Upstream of Site-Specific Drug Delivery
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Site-Specific Drug Delivery
        8.3.1 Leading Distributors/Dealers of Site-Specific Drug Delivery
        8.3.2 Leading Consumers of Site-Specific Drug Delivery
Chapter 9 Development Trend of Site-Specific Drug Delivery (2019-2028)
    9.1 Global Site-Specific Drug Delivery Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Site-Specific Drug Delivery Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Site-Specific Drug Delivery Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Site-Specific Drug Delivery Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Site-Specific Drug Delivery Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

Sidebar Menu